Literature DB >> 8705665

Effects of anticoagulant, serum, and temperature on the natural killer activity of human peripheral blood mononuclear cells stored overnight.

B K Son1, R L Roberts, B J Ank, E R Stiehm.   

Abstract

The effects of immediate versus delayed cell separation, storage temperature, presence of serum, and type of anticoagulation on the natural killer (NK) cytotoxicity of human mononuclear cells were assessed. The NK cytotoxicity of Ficoll-Hypaque-separated peripheral blood mononuclear cells (PBMC) was tested in a 3-h chromium-51 release assay with K562 cells at various effector/target cell ratios. The NK activities of PBMC from blood anticoagulated with either heparin or EDTA and then immediately separated and assayed were not different (42.9 +/- 2.5% for heparin and 40.3 +/- 4.6% for EDTA). When these separated cells were cultured in medium with 10% fetal calf serum and stored at 4,25, or 37 degrees C for 18 h before the assay, there was a significant increase in cytotoxicity. PBMC from blood stored in heparin or EDTA for 18 h before separation had reduced NK cytotoxicity, particularly if they were kept at 37 degrees C. When separated PBMC were cultured in medium with 10% human AB serum, however, samples held at 25 and 37 degrees C decreased in cytotoxicity but samples held at 4 degrees C maintained the cytotoxicity demonstrated at the baseline level with fresh cells. We recommend that heparinized blood be used for NK assays and that the PBMC be isolated immediately and held overnight at 4 degrees C in medium with 10% AB serum if the assay must be delayed. The NK cytotoxicity under these storage conditions most closely matches the results obtained when the PBMC are isolated and tested on the same day. IF PBMC isolation must also be postponed, it is best to store the blood in heparinized tubes at 25 degrees C to prevent loss of cytotoxic function.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8705665      PMCID: PMC170325          DOI: 10.1128/cdli.3.3.260-264.1996

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  27 in total

1.  Immunosuppression by activated human neutrophils. Dependence on the myeloperoxidase system.

Authors:  A el-Hag; R A Clark
Journal:  J Immunol       Date:  1987-10-01       Impact factor: 5.422

2.  Inhibition of human natural killer (NK) activity by calcium channel modulators and a calmodulin antagonist.

Authors:  J J Solovera; M Alvarez-Mon; J Casas; J Carballido; A Durantez
Journal:  J Immunol       Date:  1987-08-01       Impact factor: 5.422

3.  Inhibition of mouse natural killer cytotoxicity by heparin.

Authors:  H Yamamoto; S Fuyama; S Arai; F Sendo
Journal:  Cell Immunol       Date:  1985-12       Impact factor: 4.868

4.  Inhibition of murine natural killer cell activity by prostaglandins.

Authors:  M J Brunda; R B Herberman; H T Holden
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

5.  Regulation of human lymphocyte-mediated natural killer (NK) cell activity. I. Inhibition in vitro by peripheral blood granulocytes.

Authors:  H D Kay; D L Smith
Journal:  J Immunol       Date:  1983-01       Impact factor: 5.422

6.  Augmentation of mouse natural killer cell activity by interferon and interferon inducers.

Authors:  J Y Djeu; J A Heinbaugh; H T Holden; R B Herberman
Journal:  J Immunol       Date:  1979-01       Impact factor: 5.422

7.  Cocaine increases natural killer cell activity.

Authors:  C Van Dyke; A Stesin; R Jones; A Chuntharapai; W Seaman
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

8.  Suppression of natural killer-cell function in humans following thermal and traumatic injury.

Authors:  B A Blazar; M L Rodrick; J B O'Mahony; J J Wood; P Q Bessey; D W Wilmore; J A Mannick
Journal:  J Clin Immunol       Date:  1986-01       Impact factor: 8.317

9.  Comparison of T and B cell analyses on fresh and aged blood.

Authors:  J K Nicholson; B M Jones; G D Cross; J S McDougal
Journal:  J Immunol Methods       Date:  1984-10-12       Impact factor: 2.303

10.  Monocyte-mediated augmentation of human natural killer cell activity: conditions, monocyte and effector cell characteristics.

Authors:  E T Bloom; J T Babbitt; K Kawakami
Journal:  J Immunol       Date:  1986-07-01       Impact factor: 5.422

View more
  5 in total

1.  Association of bone loss with the upregulation of survival-related genes and concomitant downregulation of Mammalian target of rapamycin and osteoblast differentiation-related genes in the peripheral blood of late postmenopausal osteoporotic women.

Authors:  Elena V Tchetina; Karina A Maslova; Mikhail Y Krylov; Valery A Myakotkin
Journal:  J Osteoporos       Date:  2015-02-10

2.  Differences in Mammalian target of rapamycin gene expression in the peripheral blood and articular cartilages of osteoarthritic patients and disease activity.

Authors:  Elena V Tchetina; A Robin Poole; Elena M Zaitseva; Eugeniya P Sharapova; Natalya G Kashevarova; Elena A Taskina; Liudmila I Alekseeva; Liudmila A Semyonova; Svetlana I Glukhova; Alexandr N Kuzin; Maxim A Makarov; Sergey A Makarov
Journal:  Arthritis       Date:  2013-06-25

3.  Rituximab Downregulates Gene Expression Associated with Cell Proliferation, Survival, and Proteolysis in the Peripheral Blood from Rheumatoid Arthritis Patients: A Link between High Baseline Autophagy-Related ULK1 Expression and Improved Pain Control.

Authors:  Elena V Tchetina; Anastasya N Pivanova; Galina A Markova; Galina V Lukina; Elena N Aleksandrova; Andrey P Aleksankin; Sergey A Makarov; Aleksandr N Kuzin
Journal:  Arthritis       Date:  2016-01-24

4.  Deferoxamine Suppresses Collagen Cleavage and Protease, Cytokine, and COL10A1 Expression and Upregulates AMPK and Krebs Cycle Genes in Human Osteoarthritic Cartilage.

Authors:  Elena V Tchetina; Galina A Markova; A Robin Poole; David J Zukor; John Antoniou; Sergey A Makarov; Aleksandr N Kuzin
Journal:  Int J Rheumatol       Date:  2016-11-30

5.  A Flow Cytometry-Based Whole Blood Natural Killer Cell Cytotoxicity Assay Using Overnight Cytokine Activation.

Authors:  Jinho Kim; Minh-Trang Thi Phan; SoonHo Kweon; HongBi Yu; Jeehun Park; Kyeong-Hee Kim; Ilwoong Hwang; Sangbin Han; Min-Jung Kwon; Duck Cho
Journal:  Front Immunol       Date:  2020-08-14       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.